Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03173716 · ClinicalTrials.gov registry record · Phase 4
Real-Time Myocardial Perfusion Echocardiography in the ICU
A Phase 4 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 24
- Enrollment target
NCT03173716: Completed Phase 4 study, sponsored by Mayo Clinic.
NCT03173716 is a Phase 4 study that has completed, run by Mayo Clinic. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03173716, a Phase 4 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 24 participants
- Enrollment target
Study Summary
This study is being done to find out if and how much the use of RTMPE improves a provider's confidence in the diagnosis they assign. This is important because the use of RTMPE may decrease the need for any additional invasive testing.
Interventions
- PROCEDURE Definity
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2017-09-28 |
| Est. Completion | 2019-12-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03173716
The ClinicalTrials.gov registry entry for NCT03173716 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Definity is the first listed.
NCT03173716 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03173716 about?
NCT03173716 is a clinical study titled "Real-Time Myocardial Perfusion Echocardiography in the ICU". This study is being done to find out if and how much the use of RTMPE improves a provider's confidence in the diagnosis they assign. This is important because the use of RTMPE may decrease the need for any additional invasive testing.
What is the current status of trial NCT03173716?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 24 participants. The study started on 2017-09-28. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT03173716?
The interventions under investigation include: Definity (PROCEDURE).
Who is sponsoring clinical trial NCT03173716?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.